ID: ALA3249030

Max Phase: Preclinical

Molecular Formula: C48H70N14O9

Molecular Weight: 987.18

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](Cc1ccc(N)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C

Standard InChI:  InChI=1S/C48H70N14O9/c1-27(2)39(60-41(64)33(56-38(63)25-52-5)13-9-19-54-48(50)51)44(67)57-34(21-30-15-17-31(49)18-16-30)42(65)61-40(28(3)4)45(68)58-35(23-32-24-53-26-55-32)46(69)62-20-10-14-37(62)43(66)59-36(47(70)71)22-29-11-7-6-8-12-29/h6-8,11-12,15-18,24,26-28,33-37,39-40,52H,9-10,13-14,19-23,25,49H2,1-5H3,(H,53,55)(H,56,63)(H,57,67)(H,58,68)(H,59,66)(H,60,64)(H,61,65)(H,70,71)(H4,50,51,54)/t33-,34+,35-,36-,37-,39-,40-/m0/s1

Standard InChI Key:  JOBBLZSGFOBXLC-HYFOLETESA-N

Associated Targets(non-human)

Angiotensin II type 1a (AT-1a) receptor 1700 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 987.18Molecular Weight (Monoisotopic): 986.5450AlogP: -1.20#Rotatable Bonds: 27
Polar Surface Area: 360.84Molecular Species: ZWITTERIONHBA: 12HBD: 13
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 15#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.72CX Basic pKa: 11.45CX LogP: -3.29CX LogD: -4.44
Aromatic Rings: 3Heavy Atoms: 71QED Weighted: 0.02Np Likeness Score: -0.12

References

1. Hsieh K, Kiraly-Olah IC, Jorgensen EC, Lee TC..  (1979)  Angiotensin II analogues. 13. Role of the hydroxyl group of position 4 tyrosine in pressor activity.,  22  (9): [PMID:490549] [10.1021/jm00195a008]

Source